Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Microneedle patches could replace injections but need more development for better use in medicine.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

PXX is an effective and affordable photocatalyst for creating new chemical bonds in organic synthesis.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Formulation P-08-016 better targets hair follicles for baldness treatment.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Hair care products used for 4 weeks made hair smoother.

The book is a practical introduction to cosmetic dermatologic surgery for doctors.

Researchers improved a method to more accurately estimate when and how long a drug was taken using hair analysis.

The TrichoConcept™ line is effective for personalized hair loss treatments.